Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia

Vaccine. 2013 Jan 11;31(4):691-7. doi: 10.1016/j.vaccine.2012.11.043. Epub 2012 Nov 26.

Abstract

We investigated the impact of vaccination on rubella epidemiology in Australia, using a mathematical model fitted to Australian serosurvey data and incorporating pre-vaccination European estimates of rubella transmissibility. Mass infant measles-mumps-rubella (MMR) vaccination produced a 99% reduction in both rubella and congenital rubella syndrome (CRS) incidence by 2010 compared to the pre-vaccination era (1960-70). The model is consistent with reductions in CRS based on surveillance of congenital hearing impairment. Model simulations suggest that selective schoolgirl vaccination (1971-88) was associated with a 90% reduction in CRS incidence, but only a 1-4% reduction in rubella incidence. Our model predicted that these reductions in rubella were much less vulnerable to reductions in MMR vaccine coverage than for measles. In the future, a less than 15% decrease in MMR vaccine coverage is estimated to have minimal impact before 2060, but a 20% reduction may result in a 7-fold increase in rubella incidence, with the effective reproductive number R rising from 0.28 to 0.78 by 2060. The 99% reduction in both rubella and CRS incidence and low effective reproductive number (R≤0.28) we documented after 2010 are consistent with Australia having achieved rubella elimination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Australia / epidemiology
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunization
  • Infant
  • Male
  • Measles-Mumps-Rubella Vaccine / administration & dosage*
  • Measles-Mumps-Rubella Vaccine / immunology
  • Models, Biological*
  • Rubella / epidemiology
  • Rubella / immunology
  • Rubella / prevention & control*
  • Rubella / virology
  • Rubella Syndrome, Congenital / epidemiology
  • Rubella Syndrome, Congenital / immunology
  • Rubella Syndrome, Congenital / prevention & control*
  • Rubella Syndrome, Congenital / virology
  • Rubella virus / immunology*

Substances

  • Measles-Mumps-Rubella Vaccine